Hydrafacial Results Presentation Deck

2023 outlook: increasing operating leverage and accelerating China 26 $450mm to $470mm 2023E net sales +23 - 28% YoY growth Clear path to 18% - 20% adjusted EBITDA margin¹ 13.0% International launch of Syndeo → Increased focus and penetration within China Expansion of new partners and providers in US 1. Adjusted EBITDA margin is a non-GAAP measure; please refer to the disclaimer for a discussion of the definition of this measure and important information regarding the assumptions underlying the outlook; note: chart not to scale. 2022 Adj EBITDA margin 2H23 realization Opex leverage Gross margin expansion 20% 18% Potential benefit from strong China acceleration 2023E Adj EBITDA margin BEAUTYHEALTH™

View entire presentation